(Z)-N-[2-(2-hydroxyethoxy)ethyl]-9-octadecenamide

Endpoint summary

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Endpoint:

skin sensitisation: in vivo (non-LLNA)

Remarks:

Buehler Test

Type of information:

experimental study

Adequacy of study:

key study

Study period:

From March 14, 2017 and April 13, 2017

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 406 (Skin Sensitisation)

Deviations:

no

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.2600 (Skin Sensitisation)

Deviations:

no

GLP compliance:

yes

Type of study:

Buehler test

Justification for non-LLNA method:

An LLNA study was not conducted as the substance is a surfactant. Surfactants have been shown to often give false-positive results in LLNA studies.

Specific details on test material used for the study:

Appearance: yellow paste

Species:

guinea pig

Strain:

Hartley

Sex:

female

Details on test animals and environmental conditions:

Young adult, female Hartley guinea pigs from a USDA licensed supplier were used. The animals weighed 339 – 440 g at the start of the study. Prior to use, all animals were acclimated for at least five days. Animals were individually housed in wire mesh suspension cages. The animals were maintained on a 12-hour cycle light controlled room, at a temperature of 64° - 79°F and a relative humidity of 30-70%. The animals were supplied Purina Guinea Pig Chow and tap water ad libitum during both acclimation and test periods.

Route:

epicutaneous, occlusive

Vehicle:

water

Concentration / amount:

20%

Day(s)/duration:

6 h

Adequacy of induction:

highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically

Route:

epicutaneous, occlusive

Vehicle:

water

Concentration / amount:

5%

Day(s)/duration:

14 d after primary challenge, 6 h contact time

No. of animals per dose:

A total of 32 animals were utilized. Twenty test animals, ten negative control animals, and two pilot animals were used.

Details on study design:

Exposure of the guinea pigs was divided into three phases: irritation screening (1), induction (2), and challenge (3).

1. The irritation potential of the test substance at levels of 40, 20, 10 and 5% were evaluated in one group of two animals. Four levels of test substance were evaluated per animal. The day prior to test substance exposure, the hair was removed from each of the animal's backs using a small animal clipper. Closed patches were applied to the animals in the following manner. A 0.4 ml quantity of each test preparation was applied directly into a 25 mm Hilltop Chamber®. The animals were held gently, and the chambers were applied as quickly as possible to the clipped left shoulder. The chambers were secured with Micropore tape and further secured with Kendall adhesive tape. Approximately six hours later, the tape and chambers were removed.

2. The left shoulder of each test animal was clipped with a small animal clipper the day before exposure. The animals were held gently and the chambers were applied as previously described under the "Irritation Screening" section. Two additional induction doses were conducted following the same procedure, at weekly intervals. After the last induction exposure, the animals were left untreated for two weeks (14 days) before primary challenge.

3. Two weeks after the final application the animals received a topical primary challenge dose (6 hour contact) of the test substance, at 5% concentration, on a naive site located on the right shoulder. The same exposure procedure as for the "Induction Phase" was used, except the Hilltop Chambers were applied to a skin site that had not been previously exposed. Animals were scored for irritation at 24 and 48 hours after initiation of the primary challenge.

The day following the primary challenge exposure all animals were scored. The results of the primary challenge and rechallenge (if performed) are expressed in terms of both incidence and severity of responses and an assessment by comparison of responses in the test group to those of the corresponding control.

Challenge controls:

Ten guinea pigs served as a naive control group, and remained untreated through the induction phase. Six naive control animals received only the primary challenge dose, at a 5% concentration. The four remaining guinea pigs were designated for a re-challenge, if necessary.

Positive control substance(s):

no

Key result

Reading:

1st reading

Hours after challenge:

24

Group:

test chemical

Dose level:

5%

No. with + reactions:

0

Total no. in group:

20

Clinical observations:

no effects

Remarks on result:

no indication of skin sensitisation

Key result

Reading:

2nd reading

Hours after challenge:

48

Group:

test chemical

Dose level:

5%

No. with + reactions:

0

Total no. in group:

20

Clinical observations:

no effects

Remarks on result:

no indication of skin sensitisation

Key result

Reading:

1st reading

Hours after challenge:

24

Group:

negative control

Dose level:

primary challenge dose, at a 5% concentration

No. with + reactions:

0

Total no. in group:

6

Remarks on result:

no indication of skin sensitisation

Key result

Reading:

2nd reading

Hours after challenge:

48

Group:

negative control

Dose level:

primary challenge dose, at a 5% concentration

No. with + reactions:

0

Total no. in group:

6

Remarks on result:

no indication of skin sensitisation

Key result

Group:

positive control

Remarks on result:

not measured/tested

The test substance was dosed at a 20% concentration for the induction phase and a 5% concentration for the challenge phase of the study. The incidence and severity of these responses were not significantly greater than those produced by the naive control group indicating that sensitization had not been induced.

Interpretation of results:

GHS criteria not met

Conclusions:

Under the study conditions, the incidence and severity of these responses were not significantly greater than those produced by the naive control group indicating that sensitization had not been induced. The test substance was therefore considered not sensitizing to Guinea pig skin.

Executive summary:

A study was conducted to determine the skin sensitisation potential of the test substance according to OECD Guideline 406 and US EPA OPPTS 870.2600, in compliance with GLP. This Buehler test was realised on female albino Guinea pigs. A total of 32 animals were utilized; twenty test animals, ten negative control animals, and two pilot animals were used. The test substance was evaluated for sensitization potential by applying 0.4 ml at a 20% concentration directly into Hilltop Chambers® and applying them to the clipped left shoulder of twenty albino guinea pigs (induction phase). The animals were held gently, and the chambers were applied as quickly as possible to the clipped left shoulder. The chambers were secured with Micropore tape and further secured with Kendall adhesive tape. Approximately 6 h later, the tape and chambers were removed. Two additional induction doses were conducted following the same procedure, at weekly intervals. Two weeks after the final application the animals received a topical primary challenge dose (6 h contact) of the test substance at 5% concentration, on a naive site located on the right shoulder. Animals were scored for irritation (intensity and severity) at 24 and 48 hours after initiation of the primary challenge application. Ten guinea pigs served as a naive control group, and remained untreated through the induction phase. Six naive control animals received only the primary challenge dose, at a 5% concentration. The four remaining guinea pigs were designated for a re-challenge, if necessary. Following primary challenge of the test substance at 5% concentration, the incidence of grade 1 response or greater in the test group (0 of 20) was compared to that of the naive control group (0 of 6). The incidence and severity of these responses were not significantly greater than those produced by the naive control group indicating that sensitization had not been induced. Under the study conditions, the test substance was therefore considered not sensitizing to Guinea pig skin (Kukulinski, 2017).

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not sensitising)

Additional information:

A study was conducted to determine the skin sensitisation potential of the test substance according to OECD Guideline 406 and US EPA OPPTS 870.2600, in compliance with GLP. This Buehler test was realised on female albino Guinea pigs. A total of 32 animals were utilized; twenty test animals, ten negative control animals, and two pilot animals were used. The test substance was evaluated for sensitization potential by applying 0.4 ml at a 20% concentration directly into Hilltop Chambers® and applying them to the clipped left shoulder of twenty albino guinea pigs (induction phase). The animals were held gently, and the chambers were applied as quickly as possible to the clipped left shoulder. The chambers were secured with Micropore tape and further secured with Kendall adhesive tape. Approximately 6 h later, the tape and chambers were removed. Two additional induction doses were conducted following the same procedure, at weekly intervals. Two weeks after the final application the animals received a topical primary challenge dose (6 h contact) of the test substance at 5% concentration, on a naive site located on the right shoulder. Animals were scored for irritation (intensity and severity) at 24 and 48 hours after initiation of the primary challenge application. Ten guinea pigs served as a naive control group, and remained untreated through the induction phase. Six naive control animals received only the primary challenge dose, at a 5% concentration. The four remaining guinea pigs were designated for a re-challenge, if necessary. Following primary challenge of the test substance at 5% concentration, the incidence of grade 1 response or greater in the test group (0 of 20) was compared to that of the naive control group (0 of 6). The incidence and severity of these responses were not significantly greater than those produced by the naive control group indicating that sensitization had not been induced. Under the study conditions, the test substance was therefore considered not sensitizing to Guinea pig skin (Kukulinski, 2017).

Respiratory sensitisation

Endpoint conclusion

Endpoint conclusion:

no study available

Justification for classification or non-classification

The test substance was not a skin sensitizer in a Guinea pig in vivo study and therefore does not warrant classification for this endpoint according to EU CLP (EC 1272/2008) criteria.